Ehp Funds Inc. Merck & Co., Inc. Transaction History

Ehp Funds Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $475,608 - $554,190	-4,200 Reduced 68.85%	1,900 $250,000
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $290,522 - $316,158	2,900 Added 90.63%	6,100 $665,000
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $846,249 - $939,792	-8,220 Reduced 71.98%	3,200 $329,000
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $460,506 - $501,931	4,240 Added 59.05%	11,420 $1.32 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $64,852 - $72,361	630 Added 9.62%	7,180 $763,000
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $169,633 - $217,493	-1,940 Reduced 22.85%	6,550 $727,000
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $103,971 - $116,800	-1,230 Reduced 12.65%	8,490 $731,000
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $223,753 - $253,635	-2,680 Reduced 21.61%	9,720 $886,000
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $911,524 - $1.02 Million	12,400 New	12,400 $1.02 Million

3,830

1.91B

13.4M

10.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Ehp Funds Inc., based on Form 13F filings with the SEC.

Stay updated on Ehp Funds Inc. with notifications on news.